Press Releases

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

May 7, 2025

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]

Vingroup and the Rise of the ESG Ecosystem

May 7, 2025

Vingroup is positioning itself to lead Vietnam’s ESG push, using its broad business network to drive sustainable growth at home and abroad, while eyeing partnerships in the Middle East’s expanding sustainability sector. HANOI, VIETNAM – Media OutReach Newswire – 7 May 2025 – In one of Vietnam’s crowded conference halls this month, corporate leaders gathered to debate the […]

Antalpha Announces Launch of Initial Public Offering

May 6, 2025

SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its proposed initial public offering of 3,850,000 ordinary shares with expected pricing between $11.00 and $13.00 per ordinary share. Antalpha expects to grant the underwriters a 30-day option to purchase an […]